Role of hypoxia-inducible factor 1α in T cells as a negative regulator in development of vascular remodeling

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 30, Issue 2, 2010, Pages 210-217

  Kurobe, Hirotsugu ^a   Urata, Masahisa ^a   Ueno, Masaki ^b   Ueki, Masaaki ^c   Ono, Shiro ^d   Izawa Ishizawa, Yuki ^a   Fukuhara, Yayoi ^a   Lei, Yu ^a   Ripen, Adiratna Mat ^a   Kanbara, Tamotsu ^a   Aihara, Ken Ichi ^a   Ishizawa, Keisuke ^a   Akaike, Masashi ^a   Gonzalez, Frank J ^e   Tamaki, Toshiaki ^a   Takahama, Yousuke ^a   Yoshizumi, Masanori ^f   Kitagawa, Tetsuya ^a   Tomita, Shuhei ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d OSAKA OHTANI UNIVERSITY   (Japan)

^e NATIONAL CANCER INSTITUTE   (United States)

^f NARA MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Arteriosclerosis; Hif 1; Hypoxia; T cells; Vascular remodeling

Indexed keywords

GAMMA INTERFERON; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 4; T LYMPHOCYTE ANTIGEN;

ADVENTITIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTERIOSCLEROSIS; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL REACTIVITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMORAL ARTERY; IMMUNE RESPONSE; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VASCULITIS;

ANIMALS; ANTIBODY FORMATION; ARTERIOSCLEROSIS; CELL HYPOXIA; CELL PROLIFERATION; CHEMOKINE CXCL12; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; DISEASE MODELS, ANIMAL; FEMORAL ARTERY; HYPERPLASIA; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNITY, CELLULAR; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, KNOCKOUT; NITROIMIDAZOLES; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; THYMUS GLAND; TIME FACTORS; TUNICA INTIMA;

EID: 75149118269     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.109.192666     Document Type: Article

References (27)

1. Mitchell RN, Libby P. Vascular remodeling in transplant vasculopathy. Circ Res. 2007;100:967-978.
2. Dimayuga PC, Li H, Chyu KY, Fredrikson GN, Nilsson J, Fishbein MC, Shah PK, Cercek B. T cell modulation of intimal thickening after vascular injury: the bimodal role of IFN-y in immune deficiency. Arterioscler Thromb Vasc Biol. 2005;25:2528-2534.
3. Hansson GK, Holm J, Holm S, Fotev Z, Hedrich HJ, Fingerle J. T lymphocytes inhibit the vascular response to injury. Proc Natl Acad Sci USA. 1991;88:10530-10534.
4. Remskar M, Li H, Chyu KY, Shah PK, Cercek B. Absence of CD40 signaling is associated with an increase in intimal thickening after arterial injury. Circ Res. 2001;88:390-394.
5. Sartore S, Chiavegato A, Faggin E, Franch R, Puato M, Ausoni S, Pauletto P. Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: from innocent bystander to active participant. Circ Res. 2001;89:1111-1121.
6. Nakano D, Hayashi T, Tazawa N, Yamashita C, Inamoto S, Okuda N, Mori T, Sohmiya K, Kitaura Y, Okada Y, Matsumura Y. Chronic hypoxia accelerates the progression of atherosclerosis in apolipoprotein E-knockout mice. Hypertens Res. 2005;28:837-845.
7. Savransky V, Nanayakkara A, Li J, Bevans S, Smith PL, Rodriguez A, Polotsky VY. Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med. 2007;175:1290-1297. (Pubitemid 46905755)
8. Lau AK, Chaufour X, McLachlan C, Leichtweis SB, Celermajer DS, Sullivan C, Stocker R. Intimal thickening after arterial balloon injury is increased by intermittent repetitive hypoxia, but intermittent repetitive hyperoxia is not protective. Atherosclerosis. 2006;185: 254-263.
9. Bjornheden T, Levin M, Evaldsson M, Wiklund O. Evidence of hypoxic areas within the arterial wall in vivo. Arterioscler Thromb Vasc Biol. 1999;19:870-876.
10. Sluimer JC, Gasc JM, van Wanroij JL, Kisters N, Groeneweg M, Sollewijn Gelpke MD, Cleutjens JP, van den Akker LH, Corvol P, Wouters BG, Daemen MJ, Bijnens AP. Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. J Am Coll Cardiol. 2008;51: 1258-1265.
11. Vink A, Schoneveld AH, Lamers D, Houben AJ, van der Groep P, van Diest PJ, Pasterkamp G. HIF-1 alpha expression is associated with an atheromatous inflammatory plaque phenotype and upregulated in activated macrophages [published online ahead of print July 2, 2007]. Atherosclerosis. 2007;195:e69-e75.
12. Sitkovsky M, Lukashev D. Regulation of immune cells by local-tissue oxygen tension: HIF1 a and adenosine receptors. Nat Rev Immunol. 2005;5:712-721.
13. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol. 2006;6:508-519.
14. Wang GL, Semenza GL. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA. 1993;90:4304-4308.
15. Sandau KB, Zhou J, Kietzmann T, Brune B. Regulation of the hypoxia-inducible factor 1 a by the inflammatory mediators nitric oxide and tumor necrosis factor-alpha in contrast to desferroxamine and phenylarsine oxide. J Biol Chem. 2001;276:39805-39811.
16. Richard DE, Berra E, Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1a in vascular smooth muscle cells. J Biol Chem. 2000;275:26765-26771.
17. Stiehl DP, Jelkmann W, Wenger RH, Hellwig-Burgel T. Normoxic induction of the hypoxia-inducible factor 1a by insulin and interleukin-1β involves the phosphatidylinositol 3-kinase pathway. FEBS Lett. 2002;512:157-162.
18. Treins C, Giorgetti-Peraldi S, Murdaca J, Semenza GL, Van Obberghen E. Insulin stimulates hypoxia-inducible factor 1 through a phosphatidyl-inositol 3-kinase/target of rapamycin-dependent signaling pathway. J Biol Chem. 2002;277:27975-27981.
19. Makino Y, Nakamura H, Ikeda E, Ohnuma K, Yamauchi K, Yabe Y, Poellinger L, Okada Y, Morimoto C, Tanaka H. Hypoxia-inducible factor regulates survival of antigen receptor-driven T cells. J Immunol. 2003; 171:6534-6540.
20. Thiel M, Caldwell CC, Kreth S, Kuboki S, Chen P, Smith P, Ohta A, Lentsch AB, Lukashev D, Sitkovsky MV. Targeted deletion of HIF-1a gene in T cells prevents their inhibition in hypoxic inflamed tissues and improves septic mice survival. PLoS ONE. 2007;2:e853.
21. Aihara K, Azuma H, Akaike M, Ikeda Y, Sata M, Takamori N, Yagi S, Iwase T, Sumitomo Y, Kawano H, Yamada T, Fukuda T, Matsumoto T, Sekine K, Sato T, Nakamichi Y, Yamamoto Y, Yoshimura K, Watanabe T, Nakamura T, Oomizu A, Tsukada M, Hayashi H, Sudo T, Kato S. Strain-dependent embryonic lethality and exaggerated vascular remodeling in heparin cofactor II-deficient mice. J Clin Invest. 2007;117: 1514-1526.
22. Koch CJ, Evans SM, Lord EM. Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acet-amide]: analysis of drug adducts by fluorescent antibodies vs bound radioactivity. Br J Cancer. 1995;72:869-874.
23. Tomita S, Ueno M, Sakamoto M, Kitahama Y, Ueki M, Maekawa N, Sakamoto H, Gassmann M, Kageyama R, Ueda N, Gonzalez FJ, Takahama Y. Defective brain development in mice lacking the Hif-1a gene in neural cells. Mol Cell Biol. 2003;23:6739-6749.
24. Karshovska E, Zernecke A, Sevilmis G, Millet A, Hristov M, Cohen CD, Schmid H, Krotz F, Sohn HY, Klauss V, Weber C, Schober A. Expression of HIF-1 a in injured arteries controls SDF-1alpha mediated neointima formation in apolipoprotein E deficient mice. Arterioscler Thromb Vasc Biol. 2007;27:2540-2547.
25. -/- mice. Am J Pathol. 2000;157:1819-1824.
26. Jeon MS, Esser C. The murine IL-2 promoter contains distal regulatory elements responsive to the Ah receptor, a member of the evolutionarily conserved bHLH-PAS transcription factor family. J Immunol. 2000;165: 6975-6983.
27. Kojima H, Gu H, Nomura S, Caldwell CC, Kobata T, Carmeliet P, Semenza GL, Sitkovsky MV. Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1a-deficient chimeric mice. Proc Natl Acad Sci USA. 2002;99:2170-2174.